Reduced loss of enteric contents
Reduced volume of chyme discarded
Return to Oral Feeding1
91% weaned off parenteral nutrition to oral feeding within a median of two days
Restoration of Gut function2
Reverse gut atrophy and inflammation
Patient can mobilise
Untethered to IV pole
Patient Nutritional Status1
Improved Nutritional Risk Index by 10.9
Significant Economic Savings
Cost savings from reduction in parenteral nutrition and reduced length of stay in hospital
Reduced Intestinal losses1
85% reduction in intestinal losses with increased length of bowel available for absorption
Earlier discharge
Once chyme reinfusion therapy is established, patient able to rehabilitate at home
Improved Liver function3
Reduction in liver abnormalities with continued use
Reduced loss of enteric contents
Reduced volume of chyme discarded
Return to Oral Feeding1
91% weaned off parenteral nutrition to oral feeding within a median of two days
Restoration of Gut function2
Reverse gut atrophy and inflammation
Patient can mobilise
Untethered to IV pole
Patient Nutritional Status1
Improved Nutritional Risk Index by 10.9
Improved Liver function3
Reduction in liver abnormalities with continued use
Earlier discharge
Once chyme reinfusion therapy is established, patient able to rehabilitate at home
Reduced Intestinal losses1
85% reduction in intestinal losses with increased length of bowel available for absorption
Significant Economic Savings
Cost savings from reduction in parenteral nutrition and reduced length of stay in hospital
Professor Ian Bissett
Co-Founder & Chief Medical Officer
“Encourage the formation of double stomas and the consideration of the use of the distal opening for reinfusion of chyme in the setting of an enteroatmospheric fistula.”
Caution：Investigational device. Limited by United States law to investigational use.
.png){kind=small}
.png)
